These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 32832435)

  • 1. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).
    Rengasamy M; Shenoy MM; Dogra S; Asokan N; Khurana A; Poojary S; Jayaraman J; Valia AR; Sardana K; Kolalapudi S; Marfatia Y; Rao PN; Bhat RM; Kura M; Pandhi D; Barua S; Kaushal V
    Indian Dermatol Online J; 2020; 11(4):502-519. PubMed ID: 32832435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India).
    Rajagopalan M; Inamadar A; Mittal A; Miskeen AK; Srinivas CR; Sardana K; Godse K; Patel K; Rengasamy M; Rudramurthy S; Dogra S
    BMC Dermatol; 2018 Jul; 18(1):6. PubMed ID: 30041646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
    Singh S; Chandra U; Anchan VN; Verma P; Tilak R
    Br J Dermatol; 2020 Nov; 183(5):840-846. PubMed ID: 32538466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Use of Super-Bioavailable Itraconazole for the Management of Dermatophytosis: Consensus Statement by Dermatologists from India via the Modified Delphi Technique.
    Saraswat A; Dogra S; Shenoy M; Verma S; K S; Ghate S; Ganjoo A; Aurangabadkar S; Tiwari A; Poojary S; Inamdar A; Majid I; Girdhar M; Shah B; Varma S; Ramamoorthy R; Dhoot D; Barkate H
    Dermatology; 2024; 240(4):671-683. PubMed ID: 38697027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India.
    Shenoy MM; Rengasamy M; Dogra S; Kaur T; Asokan N; Sarveswari KN; Poojary S; Arora D; Patil S; Das A; Srivastava A; Katakam BK; Mahajan V
    Mycoses; 2022 Jan; 65(1):13-23. PubMed ID: 34378240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
    Patel NH; Sardana K; Shenoy MM; Rengasamy M; Khurana A; Ghate S; Venkata CK; Marfatiya Y; Bhunia D; Jayaraman J; Das A; Jain AK
    Indian Dermatol Online J; 2024; 15(1):1-7. PubMed ID: 38283009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Checkerboard Analysis To Evaluate Synergistic Combinations of Existing Antifungal Drugs and Propylene Glycol Monocaprylate in Isolates from Recalcitrant Tinea Corporis and Cruris Patients Harboring Squalene Epoxidase Gene Mutation.
    Sardana K; Gupta A; Sadhasivam S; Gautam RK; Khurana A; Saini S; Gupta S; Ghosh S
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0032121. PubMed ID: 34097482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-Mycological Profile of Treatment-Naïve, Chronic, Recurrent and Steroid-Modified Dermatophytosis at a Tertiary Care Centre in Eastern India: An Institution-Based Cross-SectionalStudy.
    Saha I; Podder I; Chowdhury SN; Bhattacharya S
    Indian Dermatol Online J; 2021; 12(5):714-721. PubMed ID: 34667758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Dermatophytosis: Real-World Indian Perspective.
    Shenoy M; Poojari S; Rengasamy M; Vedmurthy M; Barua S; Dhoot D; Barkate H
    Indian Dermatol Online J; 2023; 14(3):347-356. PubMed ID: 37266073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naive tinea corporis et cruris in an Immunocompetent adult caused by a geophile
    Vanam HP; Mohanram K; Reddy KSR; Rengasamy M; Rudramurthy SM
    Access Microbiol; 2019; 1(6):e000022. PubMed ID: 32974531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis.
    Sharma P; Bhalla M; Thami GP; Chander J
    J Dermatolog Treat; 2020 Nov; 31(7):749-753. PubMed ID: 31030594
    [No Abstract]   [Full Text] [Related]  

  • 13. End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients.
    Singh S; Shukla P
    Indian J Dermatol Venereol Leprol; 2018; 84(5):554-557. PubMed ID: 29893296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Clinical-Mycological Study of Dermatophytosis in Western India with Focus on Antifungal Drug Resistance as a Factor in Recalcitrance.
    Shah SR; Vyas HR; Shah BJ; Jangid NC; Choudhary A; Gehlawat T; Mistry D; Joshi R
    Indian J Dermatol; 2023; 68(2):234. PubMed ID: 37275803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiological prevalence and antifungal sensitivity patterns of dermatophytosis in India - A multicentric study.
    Tahiliani S; Saraswat A; Lahiri AK; Shah A; Hawelia D; Shah GK; Girdhar M; Rao PN; Raghav PA; Agarwal P; Kharkar RD; Gupta RP; Udare S; Hegde S; Haldar S
    Indian J Dermatol Venereol Leprol; 2021; 87(6):800-806. PubMed ID: 34160163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?
    Sardana K; Kaur R; Arora P; Goyal R; Ghunawat S
    Indian Dermatol Online J; 2018; 9(2):90-95. PubMed ID: 29644192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international survey of recalcitrant and recurrent tinea of the glabrous skin-A potential indicator of antifungal resistance.
    Khan SS; Hay R; Saunte DML
    J Eur Acad Dermatol Venereol; 2024 Jul; ():. PubMed ID: 39001674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study.
    Chatterjee D; Ghosh SK; Sen S; Sarkar S; Hazra A; De R
    Indian J Pharmacol; 2016; 48(6):659-664. PubMed ID: 28066103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Antifungal Agents and New Formulations Against Dermatophytes.
    Gupta AK; Foley KA; Versteeg SG
    Mycopathologia; 2017 Feb; 182(1-2):127-141. PubMed ID: 27502503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.